Contact Us  
Home  |  About Us   |  Investor Services   
Equity
   Equity Analysis
  News Analysis
  Corporate Action
  Other Market
  Company Profile
Derivatives
IPO
BSE Company News
Glenmark Pharmaceuticals Ltd.
BSE Code 532296
ISIN Demat INE935A01035
Book Value (Rs) 650.55
NSE Code GLENMARK
Dividend Yield % 0.25
Market Cap(Rs Mn) 286703.17
TTM PE(x) 68.90
TTM EPS(Rs) 14.75
Face Value (Rs) 1  
Industry : Pharmaceuticals & Drugs
  
29-Apr-2024 Glenmark Pharmaceuticals gets USFDA’s final appro...
29-Apr-2024 Glenmark Pharmaceuticals informs about press rele...
29-Apr-2024 Glenmark Pharmaceuticals moves up on getting USFD...
10-Apr-2024 Glenmark Pharmaceuticals recalls 6,528 bottles of...
01-Apr-2024 Glenmark Pharmaceuticals informs about completion...
06-Mar-2024 Glenmark Pharmaceuticals informs about disclosure
19-Feb-2024 Glenmark Pharmaceuticals informs about transcript...
01-Feb-2024 Infosys, Cochin Shipyard and Glenmark Pharmaceuti...
31-Jan-2024 Glenmark Pharmaceuticals partners with Pfizer to ...
31-Jan-2024 Glenmark Pharmaceuticals, Jubilant FoodWorks and ...
30-Jan-2024 Glenmark, Ichnos launch alliance to accelerate ne...
25-Jan-2024 Glenmark Pharmaceuticals’ arm signs license agree...
25-Jan-2024 Glenmark Pharmaceuticals informs about media rele...
25-Jan-2024 Glenmark Pharmaceuticals rises as its arm signs l...
03-Jan-2024 Glenmark Pharmaceuticals launches biosimilar of p...
Page 1 of 3
Prev || Next